Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
The 1917 Clinic has offered HIV services in Birmingham, Alabama, since 1988.
HIVMA updated its 2013 guidance on providing evidence-based primary care to people with HIV.
A study found no difference in outcomes based on whether participants took oral meds for a month before switching to injectables.
Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.
At My House Clinic, which also offers hep C and COVID-19 services, PRIDE stands for “Promotes Respect Inclusion & Dignity for Everyone.”
With the help of a $6.2 million grant, researchers at Brown University hope to find out.
Mathematical models show that HIV gains in sub-Saharan Africa could be lost, say UNAIDS and WHO.
The bilingual “How Low Can You Go?” campaign offers “life-changing news” for more than 6,400 residents.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
Should you worry about your supply? Plus: Vice President Pence and AIDS expert Deborah Birx lead the U.S. coronavirus response.
The latest revision recognizes the importance of treatment as prevention.
“This is excellent news for all children living with HIV.”
Science = life
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.